Escolar Documentos
Profissional Documentos
Cultura Documentos
It helps to establish the time limit to hold the material at different manufacturing stages and ensures that the product quality remains within the
specification during the hold time period.
World Health Organization recently published a guideline on hold time study for pharmaceutical manufacturing. The guideline provides detailed
information about the hold time study at different manufacturing stages. According to WHO TRS 992 “Annex 4 General guidance on hold-time
studies” hold time study should be done in granulation, drying, lubrication, core tablet, coating solution and coated tablet stages.
Manufacturer should prepare a flowchart of sampling for the hold time analysis. Sample should be taken and hold in the container of same material
of construction to the production area and should have the same closer system to the production.
The environmental condition of the hold time sample should be similar to the conditions in the quarantine or production stage. A headspace in the
container should be left in the same ratio as it is done in routine practice in the production stage. A sample should be taken from the hold time
sample at specified time intervals.
https://www.pharmaguideline.com/2015/06/hold-time-study-in-pharmaceutical-manufacturing.html 1/2
1/23/2019 Hold Time Study in Pharmaceutical Manufacturing : Pharmaceutical Guidelines
A hold time study protocol should be written before starting the exercise. The protocol should contain all hold time study parameters, acceptance
criteria for the analysis, type of container, volume of sample, storage conditions, the frequency of sampling, method of analysis and other required
information.
Ankur Choudhary is India's first professional pharmaceutical blogger, author and founder of Pharmaceutical Guidelines, a widely-read
pharmaceutical blog since 2008. Sign-up for the free email updates for your daily dose of pharmaceutical tips.
Need Help: Ask Question
https://www.pharmaguideline.com/2015/06/hold-time-study-in-pharmaceutical-manufacturing.html 2/2